An #AI-powered #imaging tool developed by #Brainomix has been used to enrich data from a phase 2a trial of #EndeavorBioMedicines' hedgehog pathway inhibitor #taladegib, in development for #idiopathicpulmonaryfibrosis (IPF).

pharmaphorum.com/news/brainom...